Brief: Irlab Enters Development Collaboration For IRL757

IRLAB Therapeutics AB

07/05/2024 16:05

May 7 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB ENTERS A DEVELOPMENT COLLABORATION FOR IRL757 AS A
NOVEL
TREATMENT FOR APATHY
    * UNDER CURRENT COLLABORATION, IRLAB IS ELIGIBLE TO RECEIVE
3
MILLION USD IN UP-FRONT PAYMENT AND UP TO AN ADDITIONAL 5.5
MILLION USD FOLLOWING ACHIEVEMENT OF CERTAIN DEVELOPMENT
MILESTONES

Source text for Eikon:  ID:nMFN2QBV89 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))